Related Experiment Videos
Serum alpha 1-microglobulin and beta 2-microglobulin for the estimation of fetal glomerular renal function
S Nolte1, B Mueller, W Pringsheim
1Universitäts-Kinderklinik, Freiburg, Federal Republic of Germany.
Abstract:
As proteins cannot cross the placenta levels of the microproteins alpha 1-microglobulin (alpha 1MG) and beta 2-microglobulin (beta 2 MG) can be used to assess fetal glomerular renal function. alpha 1MG, beta 2MG and creatinine were routinely determined in cord and maternal blood of 133 newborns [gestational age (GA) 25-42 weeks]. Twenty-nine patients with suspected impaired maternal or fetal renal function were studied separately and two fetuses were studied in utero. The mean fetal beta 2MG concentration fell from 3.87 +/- 0.56 mg/l in the 25-31 weeks GA group to 2.60 +/- 0.50 mg/l in the mature newborn group. alpha 1MG concentration fell from 3.10 +/- 0.51 to 2.25 +/- 0.49 mg/dl. In contrast, the mean maternal beta 1MG concentration rose from 1.73 +/- 0.69 mg/l in the 25-31 weeks GA group to a mean of 1.83 +/- 0.48 mg/l in the mature newborn group; alpha 1MG rose from 3.96 +/- 0.58 to 4.33 +/- 1.6 mg/dl. Maternal and fetal creatinine levels were identical. Fetal microprotein levels fall during intra-uterine development as glomerular filtration rate (GFR) rises. There is no correlation between cord blood and maternal alpha 1MG or beta 2MG concentrations. In 13 children with urological anomalies only 1 had elevated microprotein levels and he later developed renal insufficiency. Determination of microprotein levels in fetal serum can be used to detect severe renal function disturbances and to estimate GFR independently of maternal renal function.
Insights
Fetal microproteins, alpha 1-microglobulin (alpha 1MG) and beta 2-microglobulin (beta 2MG), can assess fetal kidney function. Levels decrease with gestational age, indicating rising glomerular filtration rate (GFR) and detecting renal issues.
Area of Science:
- Perinatal medicine
- Nephrology
- Biochemistry
Background:
- Proteins do not cross the placenta, making fetal microproteins reliable indicators of fetal kidney function.
- Alpha 1-microglobulin (alpha 1MG) and beta 2-microglobulin (beta 2MG) are endogenous proteins useful for assessing glomerular filtration rate (GFR).
Purpose of the Study:
- To evaluate the utility of alpha 1-microglobulin (alpha 1MG) and beta 2-microglobulin (beta 2MG) levels in fetal serum for assessing fetal glomerular renal function.
- To establish reference ranges for these microproteins during fetal development and compare them with maternal levels.
Main Methods:
- Alpha 1-microglobulin (alpha 1MG), beta 2-microglobulin (beta 2MG), and creatinine levels were measured in cord blood and maternal blood from 133 newborns (gestational age 25-42 weeks).
- A subset of 29 patients with suspected impaired maternal or fetal renal function and two fetuses in utero were specifically studied.
- Maternal and fetal serum samples were analyzed using routine laboratory methods.
Main Results:
- Fetal beta 2-microglobulin (beta 2MG) levels decreased from 3.87 mg/l at 25-31 weeks GA to 2.60 mg/l in mature newborns.
- Fetal alpha 1-microglobulin (alpha 1MG) levels decreased from 3.10 mg/l to 2.25 mg/dl over the same gestational age range.
- Maternal microprotein levels showed an inverse trend, rising with gestational age, and showed no correlation with fetal levels. Fetal and maternal creatinine levels were identical.
Conclusions:
- Fetal microprotein levels, specifically alpha 1-microglobulin (alpha 1MG) and beta 2-microglobulin (beta 2MG), decrease during intrauterine development, correlating with an increasing glomerular filtration rate (GFR).
- These microprotein measurements are independent of maternal renal function and can effectively detect severe fetal renal function disturbances.
- The study supports the use of fetal serum microprotein levels for estimating fetal GFR and identifying renal insufficiency in newborns.